Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Por um escritor misterioso
Descrição
Cryptosporidiosis Drug Discovery: Opportunities and Challenges
Rudimentary Structure-Activity-Relationship study of the MMV Pathogen Box compound MMV675968 (2,4-diaminoquinazoline) unveils novel inhibitors of Trypanosoma brucei brucei DHFR enzyme
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Recombinant NMT myristoylates a Leishmania substrate protein in E.
Targeting RNA structures with small molecules
Resolution achieved by automated reprocessing of data vs the resolution
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Sequence requirement for NMT lysine myristoylation a Cellular Alk12
Wellcome Centre for Anti-Infectives Research 6 year Report by Wellcome Centre for Anti-Infectives Research, Dundee - Issuu
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
ACS Infectious Diseases
Full article: Drug target identification in protozoan parasites
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Targeting RNA structures with small molecules
Frontiers Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
de
por adulto (o preço varia de acordo com o tamanho do grupo)